充血性心力衰竭 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

中文

Home

AT CBS

•　General Information •　Welcome Message •　Association and Affiliations •　Contact Us

Faculty

•　Course Directors •　Director of Consultative Commi •　Director of Academic Committee •　Members of Academic Committee •　General Secretary •　International Faculty •　Hong Kong and Taiwan Faculty •　Domestic Faculty

Program

•　Program at a Glance •　Program Search

Events

•　Slides •　Photos •　Interviews •　Videos

Scientific Library

•　Abstract

•　Acute Myocardial Infarction

•　Bifurcation Stenting

•　Cardio-oncology

•　Congestive Heart Failure

•　DAPT Duration

•　Drug Coated Balloon

•　Fractional Flow Reserve

•　IVUS Guidance

•　Optical Coherence Tomography

•　Pulmonary Hypertension

•　Rotational Atherectomy

•　Shear Stress

•　Stenting Left Main

•　Recommeded Article •　Top 10 Literature

Registration

•　Registration Information •　Faculty Registration •　International Registration

History

•　CBS2016 •　CBS2015 •　CBS2014 •　CBS2013 •　CBS2012

Home < 科学研究 < 文章摘要 < 充血性心力衰竭 <

充血性心力衰竭

Abstract

Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates
Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure
Good response to tolvaptan shortens hospitalization in patients with congestive heart failure
Respiratory Syncytial Virus and Associations With Cardiovascular Disease in Adults
Can We Use the Intrinsic Left Ventricular Delay (QLV) to Optimize the Pacing Configuration for Cardiac Resynchronization Therapy With a Quadripolar Left Ventricular Lead?
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems
HFpEF: From Mechanisms to Therapies
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial
Heart failure with preserved ejection fraction: from mechanisms to therapies

|<< 1 2 3 4 5 6 7 ...>>|

Clinical Trial

February 6, 2018, Volume 137, Issue 6

JOURNAL：Circulation

Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study

M .Kosiborod, CVD-REAL Investigators and Study Group.

Keywords: SGLT2 inhibitor; death; diabetes mellitus; heart failure; observational studies

FULL TEXT PDF